We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SU icon
151
Suncor Energy
SU
$77.7B
$4.28M 0.11%
+165,667
New +$4.57M
AAPL icon
152
PUT
Apple
AAPL
$4.89T
$4.21M 0.11%
160,000
+64,000
+67% +$1.83M
BA icon
153
PUT
Boeing
BA
$165B
$4.19M 0.11%
29,000
-42,500
-59% -$6.12M
DD icon
154
DuPont de Nemours
DD
$18.6B
$4.14M 0.11%
31,748
+22,717
+252% +$2.92M
ORCL icon
155
Oracle
ORCL
$331B
$4.08M 0.11%
111,651
-90,649
-45% -$3.46M
VRSN icon
156
VeriSign
VRSN
$25.3B
$4.03M 0.11%
46,112
+11,838
+35% +$987K
HUM icon
157
Humana
HUM
$46.7B
$4.02M 0.11%
22,500
+21,356
+1,867% +$3.75M
VMC icon
158
CALL
Vulcan Materials
VMC
$36.3B
$3.99M 0.11%
42,000
-29,000
-41% -$2.81M
IONS icon
159
Ionis Pharmaceuticals
IONS
$9.35B
$3.98M 0.11%
64,225
+57,417
+843% +$3.1M
RVTY icon
160
Revvity
RVTY
$12.3B
$3.98M 0.11%
74,254
+56,274
+313% +$2.87M
ETN icon
161
Eaton
ETN
$157B
$3.93M 0.1%
75,544
+22,135
+41% +$1.2M
KLIC icon
162
Kulicke & Soffa
KLIC
$5.3B
$3.93M 0.1%
336,534
+321,661
+2,163% +$3.5M
NOC icon
163
Northrop Grumman
NOC
$77B
$3.9M 0.1%
20,637
+12,273
+147% +$2.25M
LMT icon
164
Lockheed Martin
LMT
$134B
$3.83M 0.1%
+17,637
New +$3.83M
STZ icon
165
Constellation Brands
STZ
$22.2B
$3.82M 0.1%
26,795
-4,521
-14% -$623K
TGT icon
166
Target
TGT
$62.1B
$3.79M 0.1%
52,245
+39,645
+315% +$2.96M
GLW icon
167
Corning
GLW
$126B
$3.79M 0.1%
207,413
+178,623
+620% +$3.24M
TSN icon
168
Tyson Foods
TSN
$20.2B
$3.77M 0.1%
+70,755
New +$3.4M
NFLX icon
169
Netflix
NFLX
$292B
$3.77M 0.1%
+329,560
New +$3.77M
INTU icon
170
Intuit
INTU
$81.1B
$3.76M 0.1%
38,978
+29,225
+300% +$2.83M
XLF icon
171
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
$3.75M 0.1%
+179,595
New +$3.78M
CMCSA icon
172
CALL
Comcast
CMCSA
$79.1B
$3.73M 0.1%
132,000
MTD icon
173
Mettler-Toledo International
MTD
$26.8B
$3.7M 0.1%
10,900
+8,855
+433% +$2.84M
RGA icon
174
Reinsurance Group of America
RGA
$15.7B
$3.67M 0.1%
42,865
+40,228
+1,526% +$3.64M
YUM icon
175
CALL
Yum! Brands
YUM
$41B
$3.65M 0.1%
+69,550
New +$3.63M

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.